Chugai Pharmaceutical (4519.T) Financial Analysis & Valuation | Quarter Chart

Chugai Pharmaceutical (4519.T)

4519.T
Price: $46.54
Fair Value: 🔒
🔒score
Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals in Japan and internationally. The company's products for oncology primarily include Avastin, Tecentriq, Perjeta, Alecensa, ... more
Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, developmen... more
Description Shares
Market Cap$76.60BExchangeJPX
SectorHealthcareIndustryDrug Manufacturers - General
CountryJPCEOOsamu Okuda
IPO Date2000-01-04CAGR0.08%
Employees5,026Websitewww.chugai-pharm.co.jp
Div. Yield5.95%Payout Ratio0.99%
Buy Back Yield—Total Yield5.95%
4519.T chart loading...
Fundamentals Technicals
Enterprise Value$13763.82BP/E Ratio26.3
Forward P/E—PEG Ratio1.54
P/S Ratio5.82P/B Ratio3.95
P/CF Ratio16.91P/FCF Ratio19.89
EPS$1.77EPS Growth 1Y10.26%
EPS Growth 3Y43%EPS Growth 5Y114.55%
Revenue Growth 1Y5.65%Gross Margin0.71%
Operating Margin0.48%Profit Margin0.35%
ROE0.23%ROA0.2%
ROCE0.32%Current Ratio4.7
Quick Ratio3.82Cash Ratio1.28
Debt/Equity0.01Interest Coverage631.68
Altman Z Score24.85Piotroski Score4

View Chugai Pharmaceutical financial charts →